業績

2010年度 :: 学会発表 :: 国際学会 :: 業績

The 45th Annual Meeting of the European Association for the Study of the Liver (EASL).
2010. 4. Viena, Austlia

<Poster>
Karino Y, Kimura M, Arakawa T, Nakajima Y, Kuwata Y, Akaike J, Ozeki I, Sato T, Ohmura T, Toyota J.
Relationship of serum IP-10 levels which reflects hepatic interferon stimulating gene induction and antiviral effect of PEG/RBV combination therapy in patient with chronic hepatitis C.

Interventional Hepatology.
2010. 5. Ravello, Italy

<Oral Presentation>
Sato T.
Diagnosis of Gastric Varices and Evaluation of the Effectiveness of Treatments for Gastric Varices using Transabdominal Color Doppler Ultrasonography.

THE 9th JAPAN-KOREA JOINT SYMPOSIUM ON GASTROINTESTINAL ENDOSCOPY.
2010. 5. Tokyo, Japan

<Poster>
Ikari S, Hirayama M, Kato T, Hotta S.
Comparison of Virtual Endoscopic Analysis by Multislice CT and Diffusion-Weighted MRI for the Detection of Gastric Cancer and Lymph Node Metastasis.

2010 ASCO Annual Meeting.
2010. 6. Chicago, USA

<Poster>
Nishida T, Sawaki A, Doi T, Yamada Y, Komatsu Y, Kanda T, Kakeji Y, Onozawa Y, Yamasaki M, Ohtsu A.
Phase II Trial of Nilotinib as Third-line Therapy for Gastrointestinal Stromal Tumor (GIST) Patients in Japan.

Sawaki A, Kanda T, Komatsu Y, Nishida T.
Impact of imatinib plus best supportive care in imatinib- and sunitinib-exposed patients with refractory advanced gastrointestinal stromal tumor.

15th Congress of the European Hematology Association.
2010. 6. Barcelona, Spain

<Poster>
Shigematsu A, Kobayashi N, Minauchi K, Kobayashi H, Mori A, Masauzi N, Umehara S, Fukuhara T, Kurosawa M, Haseyama M, Hashino S, Nishio M, Kondo T, Tanaka J, Kasai M, Imamura M.
RETROSPECTIVE ANALYSIS FOR 272 PATIENTS WITH MATURE T-CELL NEOPLASMS IN HOKKAIDO, JAPAN.

The 14th Meeting of IAP and The 41st Annual Meeting of JPS.
2010. 7. Fukuoka, Japan

<Symposium>
Onodera M, Kawakami H, Kuwatani M, Haba S, Kondo S, Asaka M.
EUS-guided Drainage of the Pancreatic Fistula or Pancreatic Duct Dilatation after Resection of the Pancreas: A New Alternative?

<Oral Presentation>
Haba S, Kawakami H, Kuwatani M, Onodera M, Eto K, Kubota K, Asaka M.
The Effectiveness of EUS-FNA in Diagnosing Pancreatic Lesions.

Kuwatani M, Kawakami H, Asaka M.
Comparison between CT and EUS in diagnosis of local advance of pancreatic cancer.

14th International Congress of Immunology.
2010. 8. Kobe, Japan

<Poster>
Morita R, Hirohashi Y, Torigoe T, Takahashi A, Nakazawa E, Asanuma H, Inoda S, Hashino S, Asaka M, Sato N.
Identification of novel tumor antigen, OR7C1, in colon cancer stem cells.

9th Asian Clinical Oncology Society.
2010. 8. Gifu, Japan

<Oral Presentation>
Nakatsumi H, Yuki S, Sogabe S, Sonoda N, Muto S, Takano M, Kudo M, Kato K, Oda H, Miyagishima T, Uebayashi M, Meguro T, Asaka M, Komatsu Y.
The optimal dose period of indisetron tablets for preventing chemotherapy-induced nausea and vomiting (CINV) induced by mFOLFOX6: an exploratory trial -HGCSG0703-.

EUROSON2010.
2010. 8. Copenhagen, Denmark

<Poster>
Sato T, Akaike J, Ohmura T, Arakawa T, Karino Y, Toyota J.
Color Doppler findings of vesical varices in two patients with portal hypertension.

HCV2010.
2010. 9. Yokohama, Japan

<Poster>
Karino Y, Kimura M, Arakawa T, Nakajima Y, Kuwata Y, Akaike J, Ozeki I, Sato T, Ohmura T, Toyota J.
Serum IP-10 value, a surrogate marker of interferon stimulating gene induction, is associated with response to PEG-IFN-alpha and ribavirin therapy in patients with chronic hepatitis C.

18th United European Gastroenterology Week.
2010. 10. Barcelona, Spain

<Oral Presentation>
Mabe M, Fukase K, Kawata S.
Successuful eradication of Helicobacter pylori decrease the incidence of newly developed Gastric cancer, compared with persistent infection.

<Poster>
Ono S, Kato M, Nakagawa S, Shimizu Y, Asaka M.
Evaluation of Helicobacter pylori eradication therapy using magnifying endoscopy: comparison with 13C-urea breath test and histology.

Sato T, Yamazaki K, Akaike J.
Clinicopathological features and treatments of ectopic varices with portal hypertension.

Sato T, Yamazaki K, Akaike J.
Endoscopic procedures and interventional radiology for rectal varices.

Shimizu Y, Yoshida T, Kato M, Ono S, Kubota K, Asaka M.
Low-grade dysplasia component in superficial esophageal squamous cell carcinoma.

Yamamoto K, Kato M, Nakagawa M, Ono S, Asaka M.
Clinicopathological analysis of early gastric cancers after Helicobacter pylori eradication.

1st ISCT Asia-Pacific Regional Meeting.
2010. 10. Miyazaki, Japan

<Seminar>
Ogasawara M, Yamakawa T, Katsura Y, Shima K, Matsukawa T, Kanaya M, Minauchi K, Nakata M, Ota S, Imai K, Hirano T, Kobayashi N, Kiyama Y.
Generation of clinical grade dendritic cells for cancer immunotherapy.

The 35th ESMO Congress, Milan 2010.
2010. 10. Milano, Italy

<Poster>
Tsuji A, Denda T, Tsuji Y, Satoh T, Yoshida M, Nishina Y, Nagase M, Komatsu Y, Kato T, Muro K.
Phase II Study of First-line Sunitinib in Combination with Irinotecan, Leucovorin, and 5-fluorouracil (FOLFIRI) in Japanese Patients with Unresectable/Metastatic Colorectal Cancer.

Komatsu Y, Yuki S, Sogabe S, Nakamura M, Hatanaka K, Miyagishima T, Kudo M, Munakata M, Sakata Y, Asaka M.
Phase II Trial of Combined Chemotherapy with Irinotecan, S-1, and Bevacizumab in Patients with Metastatic Colorectal Cancer.

22nd EORTC-NCI-AACR symposium.
2010. 11. Berlin, Germany

<Poster>
Oizumi S, Ando Y, Kitagawa K, Morita S, Komatsu Y, Yuki S, Fujiwara Y, Kiyota N, Kobayashi T, Minami H.
A Phase 1A, Dose-Escalating Study of LBH589 Administered Intravenously in Adult Patients With Advanced Solid Tumors.

3rd Annual Asia Pacific and Japan Scientific Symposium.
2010. 11. Ho Chi Minh City, Vietnam

<Symposium>
Kato M.
Prevention of gastric cancer development by eradication of Helicobacter pylori infection.

EUS2010 17th International Symposium On Endoscopic Ultrasonography.
2010. 11. Shanghai, China

<Poster>
Haba S, Hijioka S, Sawaki A, Mizuno N, Hara K, Saeki A, Ogura T, Tomono T, Shimizu S, Senda Y, Sano T, Shimizu Y, Niwa Y, Yamao K.
Usefullness of EUS and EUS-FNAB for the metastatic pancreas cancers.

61st American Association For The Study OF Liver disease.
2010. 11. Boston, USA

<Poster>
Karino Y, Kimura M, Arakawa T, Nakajima Y, Kuwata Y, Akaike J, Ozeki I, Sato T, Ohmura T, Toyota J, Chayama K.
Serum IP-10 value, a surrogate marker of interferon stimulating gene induction, is associated with response to PEG-IFN-alpha and ribavirin therapy, and low level in TT group at the polymorphic site rs8099917 of IL28B.

52nd ASH Annual Meeting and Exposition.
2010. 12. Orlando, USA

<Oral Presentation>
Kodera Y, Yamamoto K, Kato S, Harada M, Kanda Y, Hamajima N, Asano S, Ikeda Y, Imamura M, Kawa K, Morishima Y, Nakahata T, Tanimoto M, Dohy H, Tanosaki R, Shiobara S, Kim S-W, Nagafuji K, Hino M, Miyamura K, and Suzuki R.
Safety and risk of allogeneic peripheral blood stem cell donation: The comprehensive report of nation-wide consecutively pre-registered 3,264 family donor survey in 10 years project by Japan Society for Hematopoietic Cell Transplantation.

<Poster>
Ogasawara M, Yamakawa T, Katsura Y, Shima K, Matsukawa T, Kanaya M, Minauchi K, Nakata M, Ota S, Imai K, Hirano T, Kobayashi N, Kiyama Y, Hirano N.
Efficient generation of HLA-A24-restricted WT1-specific cytotoxic T lymphocytes using gene-engineered artificial antigen-presenting cells.

2011 Gastrointestinal Cancers Symposium.
2011. 1. San Francisco, USA

<Poster>
Bando H, Yoshino T, Shinozaki E, Yuki S, Nishina T, Kadowaki S, Yamazaki K, Tsuchihara K, Fujii S, Yamanaka T.
Clinical outcome in patients with metastatic colorectal cancer harboring KRAS p.G13D mutation treated with Cetuximab-GI-biomarker 0902.

Kim Y. H., Sasaki Y, Lee K H, Rha S Y, Park S, Boku N, Komatsu Y, Kim T, Kim S, Sakata Y.
Randomized phase II study of nimotuzumab, an anti-EGFR antibody, plus irinotecan in patients with 5-fluorouracil-based regimen-refractory advanced or recurrent gastric cancer in Korea and Japan.

Yuki S, Shitara K, Yoshida M, Takahari D, Utsunomiya S, Yokota T, Sato Y, Tajika M, Muro K.
Phase II Study of Combination Chemotherapy with Biweekly Cetuximab and Irinotecan for Wild-type KRAS Metastatic Colorectal cancer Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidines.

Yuki S, Nakatsumi H, Tateyama M, Uehata Y, Kudo M, Kato K, Miyagishima T, Uebayashi M, Asaka M, Komatsu Y.
The optimal dose period of indisetron tablets for preventing chemotherapy-induced nausea and vomiting (CINV) induced by mFOLFOX6: an exploratory trial -HGCSG0703-.

2011 BMT Tandem Meeting.
2011. 2. Hawaii, USA

<Poster>
Ogasawara M, Yamakawa T, Katsura Y, Shima K, Matsukawa T, Kanaya M, Minauchi K, Ota S, Nakata M, Imai K, Hirano T, Kobayashi N, Kiyama Y.
Analysis of the FLT3ITD and NPM1 mutations in AML patients with intermediate risk reseiving allogeneic stem-cell transplantation.

>